经尿道前列腺等离子腔内剜除术在治疗前列腺增生症中的应用

Plasmakinetic enuclation resection of the prostate for the treatment of benign prostate hyperplasia

目的探讨经尿道前列腺等离子腔内剜除术(PKERP)治疗前列腺增生症(BPH)中的有效性。方法入选BPH患者60例,随机分为两组;研究组30例采用经尿道前列腺等离子腔内剜除术(PKERP),对照组30例应用常规经尿道前列腺等离子切除术(PKRP)。对比两组患者的手术时间,出血量,术后住院时间,术中术后并发症的情况。结果研究组和对照组的平均手术时间分别为65 min和90 min(P<0.05),平均出血量100 ml和180 m(lP<0.05)平均术后住院时间4 d和6 d(P<0.05);研究组发生1例包膜切穿,冲洗液外渗发生率3%,对照组发生3例包膜切穿,冲洗液外渗发生率10%(P<0.05);研究组短期尿路刺激症状者5例(15%),对照组短期尿路刺激症状者11例(37%)(P<0.05)。结论PKERP是治疗BPH的有效手术方法,具有切除腺瘤彻底、手术时间短、出血少、住院时间短、并发症少等优点。

Objectives To evaluate the clinical outcome of the technique of pasmakinetic enuclation resection of the prostate （PKERP） for the treatment of benign prostate hyperplasia （BPH）. Methods 30 cases of BPH were randomly classified into PKERP group and the other 30 cases into plasmakinetic resection of prostate （PKRP） group. Operative time, amount of blood loss, hospitalization days and complications of two groups were compared. Remits Mean operative time of PKERP and PKRP were 65min and 90 min respectively, mean blood loss 100 ml and 180 ml, mean hospitalization days 4 days and 6 days. Prostate capsule perforation occurred in one case of PKERP （10%） and in 3 cases of PKRP （10%）. Short term irritative symptoms were recorded in 5 cases of PKERP （15%） and 11 cases of PKRP （37%）. Coneltmions PKERP is effective, safe, and economical for the treatment of BPH.